Mingyan Lin
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 4
- Aging top 5%
- Urology top 2%
- Molecular Biology top 5%
- RNA Research and Splicing 8
- Pluripotent Stem Cells Research 7
- RNA modifications and cancer 7
- Congenital heart defects research 5
- Epigenetics and DNA Methylation 4
- Developmental Neuroscience top 5%
-
- Genetics and Neurodevelopmental Disorders 7
- Co-authors
- Deyou ZhengHerbert M. LachmanErika PedrosaAnastasia HrabovskyElaine FuchsLisa PolakWen‐Hui LienShahina B. Maqbool
- Cited by
- Cancer ResearchAgingUrology
- Journals
- PLoS ONE (7 papers)BMC Genomics (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Mingyan Lin
38 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 567
- Aging 43
- Urology 157
- Molecular Biology 1.6k
- Developmental Neuroscience 78
Countries citing papers authored by Mingyan Lin
This map shows the geographic impact of Mingyan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyan Lin more than expected).
Fields of papers citing papers by Mingyan Lin
This network shows the impact of papers produced by Mingyan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyan Lin. The network helps show where Mingyan Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingyan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 23 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 89 | |
| 8 | 2020 | 7 | |
| 9 | 2019 | 25 | |
| 10 | 2017 | 20 | |
| 11 | 2016 | 40 | |
| 12 | 2016 | 65 | |
| 13 | 2015 | 112 | |
| 14 | 2015 | 80 | |
| 15 | 2015 | 32 | |
| 16 | 2014 | 39 | |
| 17 | 2014 | 174 | |
| 18 | 2013 | 209 | |
| 19 | 2012 | 53 | |
| 20 | 2011 | 206 |
About Mingyan Lin
Mingyan Lin is a scholar working on Developmental Neuroscience, Cancer Research, Molecular Biology, Biological Psychiatry and Genetics, having authored 38 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Research and Splicing (8 papers), Cancer-related molecular mechanisms research (7 papers), Pluripotent Stem Cells Research (7 papers), RNA modifications and cancer (7 papers), Genetics and Neurodevelopmental Disorders (7 papers), Congenital heart defects research (5 papers), MicroRNA in disease regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (567 citations), Aging (43 citations), Urology (157 citations), Molecular Biology (1.6k citations) and Developmental Neuroscience (78 citations). Mingyan Lin has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Deyou Zheng, Herbert M. Lachman, Erika Pedrosa, Anastasia Hrabovsky, Elaine Fuchs, Lisa Polak, Wen‐Hui Lien, Shahina B. Maqbool, Kenneth Lay and Joseph M. Miano. Their work appears in journals such as PLoS ONE, BMC Genomics, Arteriosclerosis Thrombosis and Vascular Biology, Clinical Cancer Research and BMC Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.